Blanco-Rivero Javier, Cachofeiro Victoria, Lahera Vicente, Aras-Lopez Rosa, Márquez-Rodas Iván, Salaices Mercedes, Xavier Fabiano E, Ferrer Mercedes, Balfagón Gloria
Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma, Madrid, Spain.
Hypertension. 2005 Jul;46(1):107-12. doi: 10.1161/01.HYP.0000171479.36880.17. Epub 2005 Jun 13.
The aim of the present study was to analyze the possible involvement of vasoconstrictors prostanoids on the reduced endothelium-dependent relaxations produced by chronic administration of aldosterone in Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). For this purpose, acetylcholine (ACh) relaxations in aortic segments from both strains were analyzed in absence and presence of the cyclooxygenase-1 (COX-1) and COX-2 inhibitor indomethacin, the specific COX-2 inhibitor NS-398, the TP receptor antagonist (SQ 29 548), the thromboxane A2 (TXA2) synthase inhibitor furegrelate, and the prostacyclin (PGI2) synthesis inhibitor tranylcypromine (TCP). In addition, COX-2 protein expression was studied by Western blot analysis. Release of prostaglandin E2 (PGE2) and the metabolites of PGF2alpha, TXA2, and PGI2, 13,14-dihydro-15-keto PGF2a, TXB2, and 6-keto-PGF1alpha, respectively, were measured. Treatment with aldosterone did not modify blood pressure levels in any strain. However, aldosterone markedly reduced (P<0.05) ACh-induced relaxations in segments from both strains in a similar extent. Indomethacin, NS-398, SQ 29 548, and TCP enhanced (P<0.05) ACh relaxations in both strains treated with aldosterone. Aortic COX-2 protein expression was higher in both strains of rats treated with aldosterone. In normotensive animals, aldosterone increases the ACh-stimulated aortic production of 13,14-dihydro-15-keto PGF2a, PGE2, and 6-keto-PGF1alpha (P<0.05). In SHR, ACh only increased the 6-keto-PGF1alpha production (P<0.05). It could be concluded that chronic treatment with aldosterone was able to produce endothelial dysfunction through COX-2 activation in normotensive and hypertensive conditions. PGI2 seems to be the main factor accounting for endothelial dysfunction in hypertensive rats, whereas other prostanoids besides PGI2 appear to be involved in endothelial dysfunction under normotensive conditions.
本研究的目的是分析血管收缩剂类前列腺素是否可能参与了醛固酮长期给药导致的Wistar Kyoto大鼠(WKY)和自发性高血压大鼠(SHR)内皮依赖性舒张功能降低。为此,在存在和不存在环氧化酶-1(COX-1)和COX-2抑制剂吲哚美辛、特异性COX-2抑制剂NS-398、TP受体拮抗剂(SQ 29 548)、血栓素A2(TXA2)合酶抑制剂呋咱甲氢龙以及前列环素(PGI2)合成抑制剂反苯环丙胺(TCP)的情况下,分析了两种品系大鼠主动脉段对乙酰胆碱(ACh)的舒张反应。此外,通过蛋白质印迹分析研究了COX-2蛋白表达。分别测定了前列腺素E2(PGE2)以及PGF2α、TXA2和PGI2的代谢产物13,14-二氢-15-酮PGF2α、TXB2和6-酮-PGF1α的释放。醛固酮处理未改变任何品系的血压水平。然而,醛固酮显著降低(P<0.05)了两种品系大鼠主动脉段对ACh诱导的舒张反应,且降低程度相似。吲哚美辛、NS-398、SQ 29 548和TCP增强(P<0.05)了醛固酮处理的两种品系大鼠对ACh的舒张反应。醛固酮处理的两种品系大鼠主动脉COX-2蛋白表达均较高。在正常血压动物中,醛固酮增加了ACh刺激的主动脉中13,14-二氢-15-酮PGF2α、PGE2和6-酮-PGF1α的生成(P<0.05)。在SHR中,ACh仅增加了6-酮-PGF1α的生成(P<0.05)。可以得出结论,在正常血压和高血压情况下,醛固酮长期治疗能够通过激活COX-2导致内皮功能障碍。PGI2似乎是高血压大鼠内皮功能障碍的主要因素,而在正常血压情况下,除PGI2外的其他类前列腺素似乎也参与了内皮功能障碍。